Literature DB >> 30819342

Neonatal Abstinence Syndrome.

Lauren M Jansson1, Stephen W Patrick2.   

Abstract

This review examines the continuum of care of opioid-exposed infants, including the assessment of the neonate, diagnosis of neonatal abstinence syndrome, management of the syndrome including nonpharmacologic and pharmacologic care, approach to breastfeeding, pediatric follow-up care, and integration of care of the mother-infant dyad.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Maternal substance use disorder; Neonatal abstinence syndrome; Neonatal opioid withdrawal syndrome; Substance-exposed infant

Mesh：

Substances：

Year:  2019        PMID： 30819342     DOI： 10.1016/j.pcl.2018.12.006

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  10 in total

1.  "Alcohol During Pregnancy? Nobody Does That Anymore": State Legislators' Use of Evidence in Making Policy on Alcohol Use in Pregnancy.

Authors:  Katie Woodruff; Sarah C M Roberts
Journal:  J Stud Alcohol Drugs       Date:  2019-05       Impact factor: 2.582

2.  Polygenic risk scores and the need for pharmacotherapy in neonatal abstinence syndrome.

Authors:  Shawana Bibi; Nathan Gaddis; Eric O Johnson; Barry M Lester; Walter Kraft; Rachana Singh; Norma Terrin; Susan Adeniyi-Jones; Jonathan M Davis
Journal:  Pediatr Res       Date:  2022-08-16       Impact factor: 3.953

3.  Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.

Authors:  Ludmila N Bakhireva; Aydan Sparks; Michael Herman; Lauren Hund; Malia Ashley; Amy Salisbury
Journal:  Pediatr Res       Date:  2021-09-29       Impact factor: 3.953

4.  Evaluating Definitions for Neonatal Abstinence Syndrome.

Authors:  Kathleen M Doherty; Theresa A Scott; Anna Morad; Travis Crook; Elizabeth McNeer; Kim S Lovell; James C Gay; Stephen W Patrick
Journal:  Pediatrics       Date:  2020-12-02       Impact factor: 7.124

5.  Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.

Authors:  Shikhar Shrestha; Melissa H Roberts; Jessie R Maxwell; Lawrence M Leeman; Ludmila N Bakhireva
Journal:  Neurotoxicol Teratol       Date:  2021-03-23       Impact factor: 4.071

6.  Behavioral and Gene Regulatory Responses to Developmental Drug Exposures in Zebrafish.

Authors:  Aleksandra M Mech; Munise Merteroglu; Ian M Sealy; Muy-Teck Teh; Richard J White; William Havelange; Caroline H Brennan; Elisabeth M Busch-Nentwich
Journal:  Front Psychiatry       Date:  2022-01-10       Impact factor: 4.157

7.  Prenatal opioid-exposed infant extracellular miRNA signature obtained at birth predicts severity of neonatal opioid withdrawal syndrome.

Authors:  Ludmila N Bakhireva; Rajesh C Miranda; Amanda H Mahnke; Melissa H Roberts; Lawrence Leeman; Xingya Ma
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

8.  Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.

Authors:  Mary Beth Sutter; Hannah Watson; Nicole Yonke; Sherry Weitzen; Lawrence Leeman
Journal:  BMC Pediatr       Date:  2022-06-15       Impact factor: 2.567

9.  Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain).

Authors:  Miriam Moreno-Ramos; Mercedes Sánchez-Barba; Rubén García Sánchez; José Antonio Mirón-Canelo; Veronica González-Nuñez
Journal:  Children (Basel)       Date:  2021-12-30

Review 10.  Clinical pharmacology and dosing regimen optimization of neonatal opioid withdrawal syndrome treatments.

Authors:  Fei Tang; Chee M Ng; Henrietta S Bada; Markos Leggas
Journal:  Clin Transl Sci       Date:  2021-05-01       Impact factor: 4.689
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.